RH

Radius Health

IPO

Patients are our everything

Boston, United States · Founded 2003 · $298.0M raised

Employees
51–200
Founded
2003
Business Model
B2B
Total Funding
$298.0M
Last Round
$43.0M Series EApr 2013
Rounds
5

About

Radius Health is a biopharmaceutical company dedicated to transforming the future for underserved patient populations in bone health. Founded in 2003 and headquartered in Boston, the company launched TYMLOS (abaloparatide) injection — FDA-approved in 2017 for postmenopausal women with osteoporosis at high risk for fracture, and in 2022 for men with osteoporosis. Radius was taken private in August 2022 through acquisition by B-FLEXION Life Sciences and Patient Square Capital.

Summary

Radius Health is a Biotech company based in Boston, United States, founded in 2003. It has raised $298.0M in total across 5 rounds, most recently a $43.0M Series E round in Apr 2013. Investors include MPM Capital, BB Biotech Ventures and HealthCare.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionAug 2022

Sign up to see all 7 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies